![](/img/cover-not-exists.png)
Efficacy and Safety of Xanomeline, a M1/M4 Receptor Preferencing Agonist, Plus Trospium, a Peripheral Muscarinic Antagonist, in Schizophrenia: Phase 2 Clinical Trial Results
Brannan, Stephen, Sawchak, Sharon, Miller, Andrew, Paul, Steven M., Breier, AlanVolume:
87
Journal:
Biological Psychiatry
DOI:
10.1016/j.biopsych.2020.02.446
Date:
May, 2020
File:
PDF, 45 KB
2020